ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

E-ISSN： 1349-7006|106|6|687-691

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.6, 2015-06, pp. : 687-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

High expression of interleukin‐11 is an independent indicator of poor prognosis in clear‐cell renal cell carcinoma

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 592-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1243-1249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 656-664

John Wiley & Sons Inc

Access to resources Recommend Favorite